Eligibility Colorectal Cancer Metastatic NCT01943786

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of stage iv colorectal adenocarcinoma.
Beschreibung

ID.1

Datentyp

boolean

patient ≥ 18 years of age.
Beschreibung

ID.2

Datentyp

boolean

ecog ps 0-1
Beschreibung

ID.3

Datentyp

boolean

life expectancy ≥ 6 months
Beschreibung

ID.4

Datentyp

boolean

candidate for first-line systemic chemotherapy according to regular clinical practice.
Beschreibung

ID.5

Datentyp

boolean

measurable disease.
Beschreibung

ID.6

Datentyp

boolean

wild-type kras
Beschreibung

ID.7

Datentyp

boolean

signed informed consent form.
Beschreibung

ID.8

Datentyp

boolean

Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient who has received prior chemotherapy for metastatic crc, except for adjuvant treatment completed at least six months before entering study.
Beschreibung

ID.9

Datentyp

boolean

patient in whom there is a contraindication for the use of any of the drugs used in first-line treatment of colorectal cancer: 5-fluorouracil,, irinotecan or cetuximab
Beschreibung

ID.10

Datentyp

boolean

Ähnliche Modelle

Eligibility Colorectal Cancer Metastatic NCT01943786

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
diagnosis of stage iv colorectal adenocarcinoma.
boolean
ID.2
Item
patient ≥ 18 years of age.
boolean
ID.3
Item
ecog ps 0-1
boolean
ID.4
Item
life expectancy ≥ 6 months
boolean
ID.5
Item
candidate for first-line systemic chemotherapy according to regular clinical practice.
boolean
ID.6
Item
measurable disease.
boolean
ID.7
Item
wild-type kras
boolean
ID.8
Item
signed informed consent form.
boolean
Item Group
C0680251 (UMLS CUI)
ID.9
Item
patient who has received prior chemotherapy for metastatic crc, except for adjuvant treatment completed at least six months before entering study.
boolean
ID.10
Item
patient in whom there is a contraindication for the use of any of the drugs used in first-line treatment of colorectal cancer: 5-fluorouracil,, irinotecan or cetuximab
boolean